Neurotoxicity of subarachnoid preservative-free S (+)-ketamine in dogs

Pain Physician

Volumn 14, Issue 1, 2011, Pages 83-90

  Gomes, Lyvia Maria R S ^a   Garcia, João Batista S ^a   Ribamar Jr , José S ^b   Nascimento, Ana Gisélia Portela ^a,b  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b UNIVERSIDADE ESTADUAL DO MARANHÃO   (Brazil)

Author keywords

Dog; Histopathology; Neurotoxicity; S(+) ketamine; Subarachnoid

Indexed keywords

DRUG PRESERVATIVE; KETAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DURA MATER; EXPERIMENTAL STUDY; FEMALE; GLIOSIS; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MALE; MICROSCOPY; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NEUROTOXICITY; NONHUMAN; SPINAL ANESTHESIA;

ANALGESICS; ANIMALS; ARACHNOIDITIS; DOGS; DURA MATER; FEMALE; FIBROSIS; INJECTIONS, SPINAL; KETAMINE; MALE; MODELS, ANIMAL; NERVE DEGENERATION; PRESERVATIVES, PHARMACEUTICAL; SPINAL CORD; SUBARACHNOID SPACE; VASCULITIS;

EID: 79251534030     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53:27-30.
2. Duque MJC, Valadao CAA, Farias A. Preemptive epidural ketamine or S(+)-ketamine in post-incisional pain in dogs: A comparative study. Vet Surg 2004; 33:361-367.
3. Kronenberg RH. Ketamine as an analgesic: Parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother 2002; 16:27-35.
4. Togal T, Demirbilek S, Koroglu A. Effects of S (+) ketamine added to bupivacaine for spinal anaesthesia for prostate surgery in elderly patients. Eur J Anaesth 2004; 21:193-197.
5. Acosta ADP, Gomar C, Correa-Natalini C. Analgesic effects of epidurally administered levogyral ketamine alone or in combination with morphine on intraoperative and postoperative pain in dogs undergoing ovariohysterectomy. Am J Vet Res 2005; 66:54-61.
6. Graven-Nielsen T, Kendall A, Henriksson KG. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000; 85:483-491.
7. Miyamoto H, Saito Y, Kirihara Y. Spinal coadministration of ketamine reduces the development of tolerance to visceral as well as somatic antinociception during spinal morphine infusion. Anesth Analg 2000; 90:136-141.
8. Smith HS. Ketamine-Induced Urologic Insult (KIUI). Pain Physician 2010; 13: E343-E346.
9. Kapural L, Kapural M, Bensitel T, Sessler DI. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements. Pain Physician 2010; 13:389-394.
10. Goldberg ME, Torjman MC, Schwartzman RJ, Mager DE, Wainer IW. Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome. Pain Physician 2010; 13:379-387.
11. Nama S, Meenan DR, Fritz WT. The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS. Pain Physician 2010; 13:365-368.
12. Amr YM. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: A prospective, randomized, double blind trial. Pain Physician 2010; 13:245-249.
13. Shirani P, Salamone AR, Schulz PE, Edmondson EA. Ketamine treatment for intractable pain in a patient with severe refractory complex regional pain syndrome: A case report. Pain Physician 2008; 11:339-342.
14. Aida S, Yamakura T, Baba H. Preemptive analgesia by intravenous lowdose ketamine and epidural morphine in gastrectomy. Anesthesiology 2000; 97:1624-1630.
15. Dal D, Tetik O, Altunkaya H. The efficacy of intraarticular ketamine for postoperative analgesia in outpatient arthroscopic surgery. Arthroscopy 2004; 20:300-305.
16. Pekoe GM, Smith DJ. Ketamine analgesia: Mediation by biogenic amine and endogenous opiate process [abstract]. Anesthesiology 1979; 51:S36.
17. Mankovitz E. Epidural ketamine. A preliminary report. S Afr Med J 1982; 61:441-442.
18. Karpinski N, Dunn J, Hansen L. Subpial vacuolar myelopathy after intrathecal ketamine: report of a case. Pain 1997; 73:103-105.
19. Stotz M, Oehen HP, Gerber H. Histological findings after long-term infusion of intrathecal ketamine for chronic pain: A case report. J Pain Sympton Manage 1999; 18:223-228.
20. Borgbjerg FM, Svensson A, Frigast C. Histopathology after repeated intrathecal injections of preservative-free ketamine in the rabbit: A light and electron microscopic examination. Anesth Analg 1994; 79, 105-111.
21. Errando CL, Sifre C, Moliner S. Subarachnoid ketamine in swine - pathological findings after repeated doses: Acute toxicity study. Reg Anesth Pain Med 1999; 24:146-152.
22. Irifune M, Shimizu T, Nomoto M. Ketamine- induced anesthesia involves the N-Methyl-D-Aspartate receptor-channel complex in mice. Brain Res 1992; 569:1-9.
23. Yamakura T, Sakimura K, Shimiji K. The stereoselective effects of ketamine isomers on heteromeric N-Methyl-D-Aspartate receptor channels. Anesth Analg 2000; 91:225-229.
24. Hager H, Marhofer P, Sitzwohl C. Caudal clonidine prolongs analgesia from caudal S(+) - ketamine in children. Anesth Analg 2002; 94:1169-1172.
25. Hawksworth C, Serpell M. Intrathecal anesthesia with ketamine. Reg Anesth 1998; 23:283-288.
26. Vranken JH, Vegth MH, Kal JE. Treatment of neuropathic cancer pain with continuous intrathecal administration of S (+) - ketamine. Acta Anest Scand 2004; 48:249-252.
27. Vranken JH, Troost D, Wegener JT, Kruis MR, Vegt MH. Neuropathological findings after continuous intrathecal administration of S (+) - ketamine for the management of neuropathic cancer pain. Pain 2005; 117:231-235.
28. Ganem EM, Vianna PT, Marques M. Neurotoxicity of subarachnoid hyperbaric bupivacaine in dogs. Reg Anesth 1996; 21:234-238.
29. Ganem EM, Vianna P, Castiglia Y. Efeitos de diferentes doses de tenoxicam sobre a medula espinhal e as meninges. Estudo experimental em cães. Brazilian J Anesthesiol 1999; 49:35-37.
30. Ganem EM, Vianna P, Marques M. Efeitos da administração subaracnóidea de grandes volumes de lidocaína a 2% e ropivacaína a 1% sobre a medula espinhal e as meninges. Estudo experimental em cães. Brazilian J Anesthesiol 2003; 53:351-360.
31. Pires SRO, Ganem EM, Marques M, Castiglia YMM. Efeitos de concentrações crescentes de lidocaína hiperbárica, administradas no espaço subaracnóideo, sobre a medula espinhal e as meninges. Estudo experimental em cães. Brazilian J Anesthesiol 2006; 56:253-262.
32. Fuller GN, Burger P. Central Nervous System. In: Sternberg SS (ed) Histology for Pathologists [2nd ed]. Lippincott Williams & Wilkins, Philadelphia, PA, 1997, pp 243-282.
33. Fletcher TF, Kitchell RL. Anatomical studies on the spinal cord segments of the dog. Am J Vet Res 1996; 27:1759-1767.
34. Brock-Utne JG, Mankowitz E, Kallichurum S. Intrathecal ketamine with preservative- histological effects on spinal nerve root of baboons. S Afr Med J 1982; 61:440-441.
35. Ahuja BR. Analgesic effect of intrathecal ketamine in rats. Br J Anaesth 1983; 55:991-995.
36. Malinovsky JM, Cozian A, Lepage JY. Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology 1991; 75:91-97.
37. Malinovsky JM, Lepage JY, Cozian A. Is ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology 1993; 78:109-115.
38. Vranken JH, Troost D, Haan P, Pennings FA, Vegt MH, Dijkgraaf MGW, Holmann MW. Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S (+) -ketamine. Anesthesiology 2006; 105:813-818.
39. Burgess FW, Woiwood MD, Lutz RL. Continuous spinal anesthesia with hyperbaric bupivacaine. A dose-response analysis. Reg Anesth 1991; 16:52-55.
40. Sheskey MC, Rocco AG, Bizzarri-Schmid M. A dose-response study of bupivacaine for spinal anesthesia. Anesth Analg 1983; 62:931-935.
41. Katzenschlager S, Deusch E, Maier P. The long-term antinociceptive effect of intrathecal S(+) - ketamine in a patient with established morphine tolerance. Anesth Analg 2001; 93:1032-1034.
42. Benrath J, Scharbert G, Gustorff B. Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain. Br J Anaesth 2005; 95:247-249.
43. Machado ABM. Neuroanatomia Funcional [2nd ed]. Atheneu, São Paulo, Brazil, 2006, pp 35-41.
44. Girolami U, Frasch MP, Anthony DC. O Sistema Nervoso. In: Scholen FJ, et al. (eds) Robins Patologia Estrutural e Funcional [5th ed]. Guanabara Koogan, Rio de Janeiro, Brazil, 1996, pp 1171-1226.
45. Rice I, Wee MYK, Thomson K. Obstetric epidurals and chronic adhesive arachnoiditis. Br J Anaesth 2004; 92:109-120.
46. Farber NB, Foster J, Duhan NL. Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry 2002; 7:32-43.
47. Wang C, Sadovova N, Fu X. The role of the n-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 2005; 132:967-977.
48. Tucker AP, Lai C, Naedson R. Intrathecal midazolam I: A cohort study investigating safety. Anesth Analg 2004; 98:1512-1520.